Glypican-3-specific T-cell receptor and its uses for immunotherapy of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the most common primary liver cancer and the third most common cause of cancer related death worldwide. Cure of HCC is only possible by complete resection in early stages, but only 1020% of tumors can be curatively resected and the risk of HCC recurrence is high. In addition, HCC is resistant to conventional radio- or chemotherapy. As a result, the prognosis of HCC remains poor and new therapies are urgently needed. The discovery of so far unknown immunodominant epitopes of the tumor-associated antigen Glypican-3 and the according HLA-A2 restricted T-cell-receptor enable the development of an adoptive T cell therapy for HCC patients. Adoptive T cell therapies showed very promising results in cancer therapy over the last years. The Science Magazine even awarded this technology as Breakthrough of the year 2013. Therefore, the current invention provides the tools for a promising new approach for the therapy of HCC.
Further information: PDF
Bayerische Patentallianz GmbH
Phone: +49 89 5480177-0
Contact
Peer Biskup
As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Superradiant atoms could push the boundaries of how precisely time can be measured
Superradiant atoms can help us measure time more precisely than ever. In a new study, researchers from the University of Copenhagen present a new method for measuring the time interval,…
Ion thermoelectric conversion devices for near room temperature
The electrode sheet of the thermoelectric device consists of ionic hydrogel, which is sandwiched between the electrodes to form, and the Prussian blue on the electrode undergoes a redox reaction…
Zap Energy achieves 37-million-degree temperatures in a compact device
New publication reports record electron temperatures for a small-scale, sheared-flow-stabilized Z-pinch fusion device. In the nine decades since humans first produced fusion reactions, only a few fusion technologies have demonstrated…